Corporate Responsibility

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease.

The outbreak of COVID-19 is a global concern, with effects filtering down to organizations close to you and me that are in critical need of assistance. Lives are disrupted, more people than ever are calling out for help, and responders are hard-pressed to meet the overwhelming demand.

The closure of schools around the world due to COVID-19 risks having a major impact on the health and nutrition of school children. Key global stakeholders such as WFP (World Food Programme)​, FAO (Food and Agriculture Organization of the United Nations), and GCNF (Global Child Nutrition Foundation)​ are actively advocating Governments to continue providing nutrition to children despite school closures

Within a holistically-designed investment process, diversity of an Executive Team and Board of Directors is a powerful variable to analyze the stock’s long-term capability of preserving and growing wealth for shareholders.

Now more than ever, in this time of market volatility & economic uncertainty, there’s a real opportunity to make the world a better place by aligning our money with our values. That starts with investing in women—and the companies that support them.

General Mills (NYSE: GIS) today released its 2020 Global Responsibility Report, highlighting progress made on the company’s long-term global commitments. The annual update, which marks 50 years of reporting for the company, outlines significant progress against and investments in four priority areas: Food, Planet, People and Community.

Verizon is donating $3 million to the COVID-19 Solidarity Response Fund for the World Health Organization (WHO) as part of a partnership with Global Citizens One World: Together At Home.

The COVID-19 pandemic has caused widespread disruption around the world. Its impact is being felt throughout every facet of society, especially among our most vulnerable.

Johnson & Johnson scientists are fast at work on a potential vaccine for Covid-19 that our company plans to provide on a not-for-profit basis.

The last few weeks have shown the world that we can come together in difficult times, using our strengths and skills to help those in need.